FDA Inspection 860689 — South Texas Blood & Tissue Center

South Texas Blood & Tissue Center — FEI 1676815

The FDA completed an inspection of South Texas Blood & Tissue Center on Dec 11, 2013 in San Antonio, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 11, 2013
Fiscal Year
2014
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
San Antonio, TX (United States)

Citations

IDCFRDescription
1236721 CFR 1271.200(a)Design appropriate, suitably located

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.